Cunningham David

Avg. Two Year Performance

64% Avg. Purchase Return

28% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	3%	21%	19%	29%	64%
Purchase Success Rate	2 of 3	3 of 3	3 of 3	3 of 3	3 of 3
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

ImmuCell Corp.

Drugs » Diagnostic Substances

Director:

Holdings: 16.0K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--